Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mildly Impaired Renal Function”

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00984113
What this trial is testing

Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Impairment
Portola Pharmaceuticals 44
Early research (Phase 1)Study completedNCT05895812
What this trial is testing

A Study in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function

Who this might be right for
Subjects With Renal ImpairmentHealthy Subjects
Shanghai Vinnerna Biosciences Co., Ltd. 24
Large-scale testing (Phase 3)Study completedNCT01363011
What this trial is testing

Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
Gilead Sciences 106
Early research (Phase 1)Study completedNCT02674581
What this trial is testing

The Pharmacokinetics and Safety of BMS-663068 Administered in Subjects With Normal Renal Function and With Mild, Moderate, Severe and End Stage Renal Dysfunction (ESRD)

Who this might be right for
HIV Infections
ViiV Healthcare 30
Early research (Phase 1)Study completedNCT01674192
What this trial is testing

Prucalopride Subjects With Renal Impairment

Who this might be right for
Constipation
Movetis 34
Early research (Phase 1)Study completedNCT05368935
What this trial is testing

Nitazoxanide Pharmacokinetic Parameters in Renal Impaired Subjects

Who this might be right for
Renal ImpairmentRenal DiseaseKidney Disease
Genfit 77
Early research (Phase 1)Study completedNCT01894256
What this trial is testing

Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal or Impaired Kidney Function

Who this might be right for
Solid Tumours
AstraZeneca 56
Early research (Phase 1)Study completedNCT01459250
What this trial is testing

Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 32
Early research (Phase 1)Study completedNCT00887627
What this trial is testing

Study to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate Kidney Function Impairment to Subjects With Normal Kidney Function

Who this might be right for
Kidney DiseasesHyponatremia
Cumberland Pharmaceuticals 25
Early research (Phase 1)Study completedNCT02320045
What this trial is testing

Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects

Who this might be right for
Renal Insufficiency
Intarcia Therapeutics 38
Early research (Phase 1)Study completedNCT02108639
What this trial is testing

To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 41
Early research (Phase 1)Study completedNCT00791401
What this trial is testing

The Pharmacokinetics of ER OROS Paliperidone in Volunteers With Normal or Impaired Renal Function

Who this might be right for
SchizophreniaRenal Impairment
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Early research (Phase 1)Not Yet RecruitingNCT07824843
What this trial is testing

Safety Study of GMDTC Injection in Participants With Solid Tumors and Cisplatin-Induced Renal Dysfunction

Who this might be right for
Cisplatin NephrotoxicityCisplatin Adverse Reaction
Guangdong Jianersheng Pharmaceutical Technology Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT01493024
What this trial is testing

Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild Hyperkalemia

Who this might be right for
HyperkalemiaChronic Kidney DiseaseKidney Dysfunction
ZS Pharma, Inc. 90
Early research (Phase 1)Study completedNCT06747520
What this trial is testing

Phase 1 Renal Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride

Who this might be right for
Renal Insufficiency
Ahon Pharmaceutical Co., Ltd. 24
Early research (Phase 1)Study completedNCT03289208
What this trial is testing

Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment

Who this might be right for
Renal ImpairmentHealthy
Shionogi 30
Early research (Phase 1)Study completedNCT06962774
What this trial is testing

An Investigational Study of ESK-001 in Participants With Normal Renal Function and Participants With Mild, Moderate, and Severe Impaired Renal Function

Who this might be right for
Renal Impairment
Alumis Inc 16
Early research (Phase 1)Study completedNCT02040597
What this trial is testing

Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal Impairment.

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Chiesi Farmaceutici S.p.A. 42
Early research (Phase 1)Study completedNCT00585143
What this trial is testing

Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly

Who this might be right for
Dyslipidemia, Renal Insufficiency
AstraZeneca 37
Early research (Phase 1)Study completedNCT06428825
What this trial is testing

Learn About the Safety of BAY3283142 in People With Mild to Moderate High Blood Pressure

Who this might be right for
Chronic Kidney DiseaseArterial Hypertension
Bayer 75
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation